<-- Back to proposed bills
Vaccine Update
08 December 2020
Type
Written Ministerial Statement
Department
Department of Health and Social Care
At a Glance
Issue Summary
The statement addresses the contingent liabilities related to the contract between HMG and Pfizer/BioNTech for their COVID-19 vaccine.
Action Requested
I have laid a Departmental Minute today containing a description of the liability undertaken in relation to the Pfizer/BioNTech vaccine, as part of the government's strategy to manage COVID-19 until an effective vaccine can be deployed at scale. The statement also notes that indemnities are provided for unforeseen adverse reactions.
Key Facts
- On December 2, the MHRA gave authorisation for the use of the Pfizer/BioNTech COVID-19 vaccine.
- The agreement includes an indemnity to secure access to vaccines with expected benefits to public health and the economy.
- Other nation states are offering indemnities as part of their contractual arrangements or other means like the US PREP Act.
▸
Assessment & feedback
Summary accuracy